Annual ROE
-94.60%
-6.54%-7.43%
01 June 2022
Summary:
Pluristem Therapeutics annual return on equity is currently -94.60%, with the most recent change of -6.54% (-7.43%) on 01 June 2022. During the last 3 years, it has fallen by -6.54% (-7.43%).PSTI ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-99.22%
-2.87%-2.98%
01 September 2022
Summary:
Pluristem Therapeutics quarterly return on equity is currently -99.22%, with the most recent change of -2.87% (-2.98%) on 01 September 2022.PSTI Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -7.4% | +0.7% |
| 5 y5 years | +32.6% | +50.1% |
PSTI ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -125.0% | -101.5% |
Pluristem Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -99.22%(+3.0%) |
| June 2022 | -94.60%(+7.4%) | -96.35%(+3.8%) |
| Mar 2022 | - | -92.82%(-7.5%) |
| Dec 2021 | - | -100.31%(+0.4%) |
| Sept 2021 | - | -99.91%(+8.8%) |
| June 2021 | -88.06%(+17.7%) | -91.84%(-3.4%) |
| Mar 2021 | - | -95.04%(-8.7%) |
| Dec 2020 | - | -104.06%(+4.2%) |
| Sept 2020 | - | -99.91%(-14.0%) |
| June 2020 | -74.82%(-46.7%) | -116.12%(-37.0%) |
| Mar 2020 | - | -184.33%(-7.0%) |
| Dec 2019 | - | -198.20%(-0.3%) |
| Sept 2019 | - | -198.71%(+7.7%) |
| June 2019 | -140.31%(+57.8%) | -184.51%(+8.2%) |
| Mar 2019 | - | -170.56%(+65.1%) |
| Dec 2018 | - | -103.31%(+8.5%) |
| Sept 2018 | - | -95.19%(+11.7%) |
| June 2018 | -88.93%(+9.4%) | -85.21%(+13.2%) |
| Mar 2018 | - | -75.30%(-24.8%) |
| Dec 2017 | - | -100.10%(+2.8%) |
| Sept 2017 | - | -97.38%(+13.5%) |
| June 2017 | -81.32%(+68.4%) | -85.82%(+11.2%) |
| Mar 2017 | - | -77.19%(+10.5%) |
| Dec 2016 | - | -69.83%(+27.2%) |
| Sept 2016 | - | -54.88%(+13.8%) |
| June 2016 | -48.28%(+17.6%) | -48.21%(+7.3%) |
| Mar 2016 | - | -44.94%(+2.3%) |
| Dec 2015 | - | -43.92%(-7.7%) |
| Sept 2015 | - | -47.59%(+3.6%) |
| June 2015 | -41.04%(-8.9%) | -45.93%(-0.7%) |
| Mar 2015 | - | -46.26%(-2.3%) |
| Dec 2014 | - | -47.35%(+0.3%) |
| Sept 2014 | - | -47.22%(+5.6%) |
| June 2014 | -45.04%(+1.4%) | -44.71%(-2.3%) |
| Mar 2014 | - | -45.74%(+16.1%) |
| Dec 2013 | - | -39.41%(+14.2%) |
| Sept 2013 | - | -34.51%(-2.0%) |
| June 2013 | -44.44%(+21.9%) | -35.20%(+8.1%) |
| Mar 2013 | - | -32.57%(-0.2%) |
| Dec 2012 | - | -32.64%(+4.3%) |
| Sept 2012 | - | -31.28%(-15.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | -36.45%(+45.9%) | -37.04%(+4.3%) |
| Mar 2012 | - | -35.52%(+17.6%) |
| Dec 2011 | - | -30.20%(-25.1%) |
| Sept 2011 | - | -40.32%(-9.0%) |
| June 2011 | -24.98%(-86.7%) | -44.33%(-26.9%) |
| Mar 2011 | - | -60.68%(-72.7%) |
| Dec 2010 | - | -222.27%(+1.3%) |
| Sept 2010 | - | -219.31%(+3.5%) |
| June 2010 | -187.21%(-4.3%) | -211.97%(-1.9%) |
| Mar 2010 | - | -216.01%(+7.1%) |
| Dec 2009 | - | -201.60%(+7.8%) |
| Sept 2009 | - | -187.03%(-9.0%) |
| June 2009 | -195.52%(-56.6%) | -205.58%(-25.2%) |
| Mar 2009 | - | -274.80%(+1.3%) |
| Dec 2008 | - | -271.34%(-3.3%) |
| Sept 2008 | - | -280.52%(+15.7%) |
| June 2008 | -450.75%(+215.4%) | -242.39%(+15.4%) |
| Mar 2008 | - | -209.99%(-16.9%) |
| Dec 2007 | - | -252.62%(-10.6%) |
| Sept 2007 | - | -282.61%(-27.1%) |
| June 2007 | -142.93%(-137.7%) | -387.81%(-64.3%) |
| Mar 2007 | - | -1085.11%(-116.6%) |
| Dec 2006 | - | 6537.19%(-193.3%) |
| Sept 2006 | - | -7005.52%(+1417.4%) |
| June 2006 | 378.72%(-425.5%) | -461.67%(+261.4%) |
| Mar 2006 | - | -127.76%(-23.3%) |
| Dec 2005 | - | -166.51%(-12.4%) |
| Sept 2005 | - | -190.04%(-27.3%) |
| June 2005 | -116.36%(-94.1%) | -261.39%(-84.5%) |
| Mar 2005 | - | -1683.89%(-61.5%) |
| Dec 2004 | - | -4374.33%(+1.0%) |
| Sept 2004 | - | -4329.07%(+55.4%) |
| June 2004 | -1985.74%(+2003.3%) | -2785.23%(+263.2%) |
| Mar 2004 | - | -766.79%(+77.8%) |
| Dec 2003 | - | -431.31%(+31.2%) |
| Sept 2003 | - | -328.82%(-17.7%) |
| June 2003 | -94.41%(-191.4%) | -399.73%(-292.8%) |
| Mar 2003 | - | 207.36%(-15.7%) |
| Dec 2002 | - | 245.89%(+4.0%) |
| Sept 2002 | - | 236.52%(+184.9%) |
| June 2002 | 103.32% | 83.02% |
FAQ
- What is Pluristem Therapeutics annual return on equity?
- What is the all time high annual ROE for Pluristem Therapeutics?
- What is Pluristem Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Pluristem Therapeutics?
What is Pluristem Therapeutics annual return on equity?
The current annual ROE of PSTI is -94.60%
What is the all time high annual ROE for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual return on equity is 378.72%
What is Pluristem Therapeutics quarterly return on equity?
The current quarterly ROE of PSTI is -99.22%
What is the all time high quarterly ROE for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly return on equity is 6537.19%